Anti-EpCAM-conjugated adeno-associated virus serotype 2 for systemic delivery of EGFR shRNA: Its retargeting and antitumor effects on OVCAR3 ovarian cancer in vivo-Reference-Cited by-同舟云学术

Anti-EpCAM-conjugated adeno-associated virus serotype 2 for systemic delivery of EGFR shRNA: Its retargeting and antitumor effects on OVCAR3 ovarian cancer in vivo

Published:2019-06 Issue: Volume:91 Page:258-269
ISSN:1742-7061
Container-title:Acta Biomaterialia
language:en
Short-container-title:Acta Biomaterialia

Author:

Lee Sungjin,Ahn Hyung Jun

Funder

National Research Foundation of Korea

KIST Institutional Program

Publisher

Elsevier BV

Subject

Molecular Biology,Biomedical Engineering,Biochemistry,Biomaterials,General Medicine,Biotechnology

Reference47 articles.

1. RNA interference and its role in cancer therapy;Mansoori;Adv. Pharm. Bull.,2014

2. Positional effects of short interfering RNAs targeting the human coagulation trigger Tissue Factor;Holen;Nucleic Acids Res.,2002

3. Recent developments in adeno-associated virus vector technology;Buning;J. Gene Med.,2008

4. Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges;Mingozzi;Nat. Rev. Genet.,2011

5. Analysis of AAV serotypes 1–9 mediated gene expression and tropism in mice after systemic injection;Zincarelli;Mol. Ther.,2008

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical strategies with antibody–drug conjugates as potential modifications for virotherapy;Drug Discovery Today;2024-09

2. Site-specific tethering nanobodies on recombinant adeno-associated virus vectors for retargeted gene therapy;Acta Biomaterialia;2024-07

3. The infectivity of AAV9 is influenced by the specific location and extent of chemically modified capsid residues;Journal of Biological Engineering;2024-05-14

4. Chemically Modified Platforms for Better RNA Therapeutics;Chemical Reviews;2024-01-29

5. The infectivity of AAV9 is influenced by the specific location and extent of chemically modified capsid residues;2024-01-15